ICH Q4B Evaluation and recommendation of pharmacopoeial texts for use in the ICH regions - Scientific guideline
ICH Q4B(R1) Guideline on evaluation and recommendation of pharmacopoeial texts for use in the ICH regions - Step 5
Frequently asked questions about parallel distribution
Human medicines European public assessment report (EPAR): Vizimpro, dacomitinib, Date of authorisation: 02/04/2019, Revision: 4, Status: Authorised
HMA / EMA Task Force on the Availability of Authorised Medicines for Human and Veterinary Use (2016-2024)
Data access to medicinal products for human use - Chapter 5 Annex A: Product data elements accessible by stakeholder group
Good practice guidance for communication to the public on medicines’ availability issues
Medicine shortages and availability issues: guidance for regulators
Guidance on the procedural aspects for the consultation to the European Medicines Agency by a notified body on companion diagnostics - Revision 1
Questions & answers - Practical arrangements on the companion diagnostics consultation procedure to the European Medicines Agency by notified bodies